Janus Henderson Investors
Investor profile
Janus Henderson Investors has backed 4 European tech companies across 4 funding rounds between 2018 and 2026, joining rounds totalling €515M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2018–2026
9 yrs
Total round €
€515M
sum of rounds joined
Deals by year
distinct rounds / yearJanus Henderson Investors — deals by year — interactive chart.
Data table
| Janus Henderson Investors — deals by year | |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Top sectors
by dealsJanus Henderson Investors — top sectors — interactive chart.
Data table
| Janus Henderson Investors — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsJanus Henderson Investors — stages — interactive chart.
Data table
| Janus Henderson Investors — stages | |
|---|---|
| Series C | 2 |
| Series B | 1 |
| Series D+ | 1 |
Countries
by dealsJanus Henderson Investors — countries — interactive chart.
Data table
| Janus Henderson Investors — countries | |
|---|---|
| UK | 3 |
| Sweden | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- SV Health Investors3
- Syncona Partners2
- Andera Partners1
- Avidity Partners1
- Bain Capital Life Sciences1
- British Business Bank1
- British Patient Capital1
- EQT Life Sciences1
- Fidelity Management & Research Company LLC1
- Forbion1
- GV1
- Invus1
- IP Group PLC1
- Jefferson Life Sciences1
- Jeito Capital1
- M Ventures1
- Monashee Investment Management LLC1
- Northpond Ventures1
- Novartis Venture Fund1
- Novo Holdings1
- Omega Funds1
- Oxford Science Enterprises1
- Pfizer Ventures1
- Piper Heartland Healthcare Capital1
- Point72 Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 1 | €273M |
| Quell Therapeutics | UK | 1 | €138M |
| Artios | UK | 1 | €99M |
| Aprea Therapeutics | Sweden | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Artios | Series D+ | €99M | 2025-11 |
| Aprea Therapeutics | Series C | €5.0M | 2019-01 |